Literatur
- 1
Barrows D, Berk J E, Fridhandler L.
Macroamylasemia:
survey of prevalence in a mixed population.
N Engl J Med.
1972;
286
1352
- 2
Berggren T, Levitt M D.
An unusual
form of macroamylasemia.
Gastroenterology.
1974;
67
149-154
- 3
Berk J E, Kizu H, Wilding P. et al .
Macroamylasemia: a newly recognized cause
for elevated serum amylase activity.
N Engl J Med.
1967;
277
941-946
- 4
Bode C, Riederer J, Brauner B, Bode J C.
Macrolipasemia:
a rare cause of persistently elevated serum lipase.
Am
J Gastroenterol.
1990;
85
412-416
- 5
Cuckow P M, Foo A Y, Jamal A, Stringer M D.
Familial
hyperamylasaemia.
Gut.
1997;
40
689-690
- 6
Dürr H K, Bindrich D, Bode J C.
The
frequency of macroamylasemia and the diagnostic value of the amylase
to creatinine clearance ratio in patients with elevated serum amylase
activity.
Scand J Gastroenterol.
1977;
12
701-705
- 7
Garcia-Gonzalez M, Defarges-Pons V, Monescillo A, Hernandes F, Cano-Ruiz A.
Macrolipasemia
and celiac disease.
Am J Gastroenterol.
1995;
90
2233-2234
- 8
Gullo L, Pezzilli R, Tomassetti P.
Unusual association
of macroamylasemia and hyperlipasemia: report of two cases.
Am
J Gastroenterol.
1996;
91
2441-2442
- 9
Gullo L.
Chronic
nonpathological hyperamylasemia of pancreatic origin.
Gastroenterology.
1996;
110
1905-1908
- 10
Gullo L.
Familial
pancreatic hyperenzymemia.
Pancreas.
2000;
20
158-160
- 11
Helmberger H, Hellerhoff K, Rull T, Brandt C, Gerhardt P.
Functional
MR-pancreatography with secretin. A comparison of imaging quality
and diagnostic value.
Röfo Fortschr Geb Röntgenstr
Neuen Bildgeb Verfahr.
2000;
172
367-373
- 12
Isenman L D, Rothman S S.
Transport
of a-amylase across the basolateral membrane of the pancreatic acinar
cell.
Proc Natl Acad Sci.
1977;
74
4068-4072
- 13
Levitt M D, Ellis C J, Meier P B.
Extrapancreatic
origin of chronic unexplained hyperamylasemia.
N Engl
J Med.
1980;
302
670-671
- 14
Miyasaka K, Rothman S S.
Endocrine
secretion of a-amylase by the pancreas.
Am J Physiol.
1981;
241
G170-G175
- 15
Okumura Y, Tamba J, Shintani Y. et al .
Macrolipasemia in Crohn«s disease.
Pancreas.
1998;
16
205-210
- 16
Permert J.
Islet
amyloid polypeptide in patients with pancreatic cancer and diabetes.
N
Engl J Med.
1994;
330
313-318
- 17
Pieper-Bigelow C, Strocchi A, Levitt M D.
Where
does serum amylase come from and where does it go?.
Gastroenterol
Clin North Am.
1990;
19
793-810
- 18
Portenoy R K, Caraceni A.
Pain management in
pancreatic carcinoma.
Cancer.
1996;
78
639-653
(Suppl 3))
- 19
Sachdeva C K, Bank S, Greenberg R, Blumstein M, Weissman S.
Fluctuations
in serum amylase in patients with macroamylasemia.
Am J
Gastroenterol.
1995;
90
800-803
- 20
Stein W, Bohner J, Bahlinger M.
Macrolipase - a
new member of the family of immunoglobulin-linked enzymes.
J
Clin Chem Clin Biochem.
1987;
25
837-843
- 21
Taes Y E, Louagie H, Yvergneaux J -P. et al .
Prolonged hyperlipasemia attributable to
a novel type of macrolipase.
Clin Chem.
2000;
46
2008-2013
- 22
Warshaw A L, Hawboldt M M.
Puzzling
persistent hyperamylasemia, probably neither pancreatic nor pathologic.
Am
J Surg.
1988;
155
453-456
- 23
Wilding P, Cooke W T, Nicholson G I.
Globulin-bound
amylase.
Ann Intern Med.
1964;
60
1053-1059
- 24
Zaman Z, van
Orshoven A, Marien G, Fevery J, Blanckaert N.
Simultaneous macroamylasemia
and macrolipasemia.
Clin Chem.
1994;
40
939-942
Priv.-Doz. Dr. med. Michael Rünzi
Abteilung für Gastroenterologie und Stoffwechselerkrankungen, Zentrum
für Innere Medizin, Kliniken Essen Süd
Propsteistraße 2
45239 Essen
Telefon: 0201/4089-2221
eMail: michael.ruenzi@cityweb.de
